FIELD: pharmaceutics.
SUBSTANCE: invention relates to griseofulvin derivatives, a pharmaceutical composition based on them, as well as to the use of a pharmaceutical composition for the prevention and/or treatment of an inflammatory disease of the central nervous system. The composition contains a compound of the general formula (1’) or its pharmacologically acceptable salt, where R1 is a C1-C6 alkyl group optionally substituted with the same or different one or two substituents selected from a substituent X group, R2 is a C1-C6 alkyl group, A is a 5-element aromatic heterocyclic ring selected from pyrazolyl and oxadiazolyl, a 6-element aromatic heterocyclic ring selected from pyridinyl and pyrimidinyl, or a single bond (if a single bond, then one or the other of R3 and R3’ is absent); R3 and R3’, each independently, is a hydrogen atom, a hydroxy group, a C1-C6 alkyl group optionally substituted with the same or different one or two substituents selected from the substituent X group, a C1-C6 alkoxy group optionally substituted with the same or different one or two substituents selected from the substituent X group, a 6-element aromatic heterocyclic group selected from piperidinyl and tetrahydropyranyl, optionally substituted with the same or different one or two substituents selected from the substituent X group, or R3 and R3’ can form a 6-element unsaturated heterocyclic ring as a ring that binds and condenses with A, and the specified ring is optionally substituted with the same or different one or two substituents selected from the substituent X group, the substituent X group is a halogen atom, a hydroxy group, C1-C6 alkyl group, C1-C6 alkoxy group.
EFFECT: new compounds are obtained, as well as a pharmaceutical composition based on them, which can be used in medicine for the treatment of an inflammatory disease of the central nervous system.
17 cl, 4 dwg, 17 tbl, 25 ex
Title | Year | Author | Number |
---|---|---|---|
GRISEOFULVIN COMPOUND | 2017 |
|
RU2736208C2 |
CYCLIC DIONES AS HERBICIDAL COMPOUNDS | 2020 |
|
RU2822391C2 |
SULPHONAMIDE COMPOUND OR SALT THEREOF | 2017 |
|
RU2732572C2 |
2-METHOXYIMINOPHENYLACETIC ACID ORTHO-SUBSTITUTED AMIDES, METHOD OF THEIR SYNTHESIS, AGENT FOR HARMFUL FUNGI CONTROL AND INSECTOACARICIDE AGENT | 1994 |
|
RU2130924C1 |
ANTITUMOR AGENT | 2018 |
|
RU2770824C2 |
AZAINDOLE DERIVATIVE | 2015 |
|
RU2649575C1 |
CYCLIC CYANOENONE DERIVATIVES AS KEAP1 MODULATORS | 2021 |
|
RU2822828C1 |
CONDENSED QUINOLINE DERIVATIVE AND USE THEREOF | 2005 |
|
RU2384571C2 |
HETEROAROMATIC MODULATORS OF RETINOL-BOUND ORPHAN GAMMA RECEPTOR | 2017 |
|
RU2771280C2 |
AGENT FOR PROPHYLAXIS AND TREATMENT OF NEUROPATHY | 2003 |
|
RU2337682C2 |
Authors
Dates
2022-06-21—Published
2018-09-28—Filed